Cellectar Biosciences Inc - Rasio nilai perusahaan marang dodolan CLRB

Simbol resmi perusahaan cellectar.com (CLRB)

The expected transition to commercialization within the orphan oncology niche will establish a foundation for high cash flow margins for Cellectar Biosciences (CLRB). The EV/Sales ratio confirms this trend, where 0.00 represents the current value of the metric. Experienced management is successfully preparing regulatory filings, while innovative radiopharmaceuticals ensure high-precision destruction of cancer cells through targeted radiation delivery to the tumor.

Cellectar Corp (CLRB): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Cellectar - rincian analitis lan metrik utama (CLRB)

Pambiji fundamental perusahaan:CLRB, cellectar.com
Produk sing diprodhuksi Cellectar Biosciences Inc

The specifics of delivering radiopharmaceuticals with short half-lives require colossal expenditures on ultra-fast logistics, which directly impacts the operational efficiency of Cellectar Biosciences (CLRB). The EV/Sales valuation reflects the enterprise value including net debt relative to revenue, allowing investors to assess the density of market expectations and the probability of price deviation from fundamental values during periods of low liquidity.

Analisis pesaing

Multiplikator nilai perusahaan marang pendapatan Incyte Corporation|HCM (HUTCHMED Corp) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Nuvation Pharma NUVB|Nilai perusahaan marang pendapatan DAWN|Multiplikator nilai perusahaan marang pendapatan Monopar Therapeutics MNPR|Nilai perusahaan marang pendapatan INBX (Inhibrx Biosciences)|IMAB (I-Mab Inc.) - Nilai bisnis marang pendapatan|Fennec Pharmaceuticals - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan HRTX (Heron Therapeutics Inc)|Nuvectis - Multiplikator EV/Sales|Nilai bisnis marang pendapatan CHRS (Coherus BioSciences Inc.)|CRBP: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cardiff Oncology Corp (CRDF)|Rasio nilai perusahaan marang pendapatan BeyondSpring|BCAB: Nilai bisnis marang pendapatan|Multiplikator EV/Sales LIXT|Multiplikator EV/Sales Citius Pharmaceuticals Inc. (CTXR)|Rasio nilai perusahaan marang pendapatan BioLineRx Corp BLRX|CANF (Can-Fite BioPharma Ltd.) - Nilai perusahaan marang volume dodolan|APRE: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Kazia Therapeutics Limited|Silexion Therapeutics Corp (SLXN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan NCNA|CMRX (Chimerix, Inc.) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Cyclacel Pharmaceuticals CYCC|G1 Therapeutics Inc. (GTHX) - Nilai bisnis marang pendapatan|KRON - Multiplikator nilai perusahaan marang pendapatan|Kintara Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Koefisien nilai perusahaan marang pendapatan ONCT (Oncternal)|Portage Biotech Corp - Multiplikator EV/Sales